A transversal approach combining in silico, in vitro and in vivo models to describe the metabolism of the receptor interacting protein 1 kinase inhibitor sibiriline

HIGHLIGHTS

• who: Romain Pelletier and colleagues from the Institut NuMeCan (Nutrition, Metabolism and Cancer), INRAE, CHU, PREVITOX Network, France Clinical and Forensic Toxicology Laboratory, University Hospital, France have published the article: A Transversal Approach Combining In Silico, In Vitro and In Vivo Models to Describe the Metabolism of the Receptor Interacting Protein 1 Kinase Inhibitor Sibiriline, in the Journal: Pharmaceutics 2022, 14, x FOR PEER REVIEW of 30/Nov/2022
• what: The authors aimed to investigate the metabolic fate of in cross-sectional manner using an in silico prediction coupled with in vitro and in vivo . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.